Gilead Sciences Announces Second Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
Gilead Sciences (GILD) Tops Q2 EPS by 14c
July 29, 2021 4:05 PM EDTGilead Sciences (NASDAQ: GILD) reported Q2 EPS of $1.87, $0.14 better than the analyst estimate of $1.73. Revenue for the quarter came in at $6.2 billion versus the consensus estimate of $6.07 billion.
GUIDANCE:
Gilead Sciences sees FY2021 EPS of $6.90-$7.25, versus the consensus of... More
